INTRODUCTION {#S1}
============

Genomes are organized in the three-dimensional (3D) nuclear space to ensure that processes such as transcription are fine-tuned in time and space ([@R39]). The first experiments using Hi-C described the segregation of chromatin into A (active) and B (inactive) compartments that interact with other genomic regions in a similar transcriptional state ([@R28]). More recently, experiments using high-resolution Hi-C data have found that the segregation of active and inactive chromatin scales to small compartmental domains of tens to hundreds of kilobases (kb) ([@R36], [@R37]; [@R40]). In addition, high-resolution Hi-C in mammalian cells has led to the discovery of thousands of point-to-point interactions representing CCCTC-binding factor (CTCF) loops ([@R36]). *Drosophila* cells lack loops anchored by CTCF ([@R40]). Instead, Hi-C heatmaps in *Drosophila* cultured cells and embryos have shown the existence of two classes of loops formed by contacts between specific sites. The first class represents hundreds of point-to-point interactions present in early embryos and whose anchors are enriched in RNA polymerase II (Pol II) and the transcription factor Zelda ([@R32]). The second class of loops was originally discovered in Kc167 cells and represents a few hundred point-to-point interactions whose anchors are enriched in other architectural proteins ([@R6]). These loops are frequently located within B compartmental domains, and their anchors are enriched in Polycomb (Pc) ([@R11]), a member of the Polycomb repressor complex 1 (PRC1) that mediates recognition and binding to the histone modification histone H3 lysine 27 trimethylation (H3K27me3) ([@R44]). Pc and most components of PRC1 lack DNA binding activity and are recruited to Polycomb response elements (PREs) containing GAGA sequence motif (GAGA) consensus binding sites by sequence-specific transcription factors ([@R45]; [@R26]; [@R20]; [@R19]; [@R13]; [@R5]). Deletion of PREs or GAGA motifs present at loop anchors results in loss of the corresponding loops and decreased Polycomb group (PcG)-mediated gene silencing during development ([@R32]). However, the GAGA binding factor or factors that mediate point-to-point interactions leading to the formation of these loops remain undefined. Two sequence-specific transcription factors, Trithorax-like/GAF ([@R52]) and Pipsqueak (Psq) ([@R26]) bind GAGA sequences. Interactions among GAF, Psq, and Pc have also been identified ([@R20]; [@R45]; [@R17]), and these physical interactions are supported by genetic interactions among these genes ([@R14]; [@R45]; [@R20]).

The *psq* gene is a complex locus encoding two types of isoforms containing or lacking a BTB domain ([@R49]). We refer to the BR-C, ttk, and bab domain (BTB)-containing Psq isoforms as Psq^L^ and the Psq isoforms lacking the BTB domain as Psq^S^. Both types of isoforms share a helix-turn-helix (HTH) DNA binding domain ([@R18]). The long Psq^L^ isoforms, like GAF, contain a conserved BTB domain involved in protein-protein interactions. BTB domain-containing proteins have the ability to oligo- and multi-merize in solution with other BTB or non-BTB-containing proteins ([@R34]; [@R53]; [@R51]). This ability and their location in distinct nuclear substructures suggest that BTB-containing proteins may interact with distant proteins in the genome, altering chromatin structure ([@R16]; [@R42]; [@R54]; [@R15]). Several *Drosophila* architectural proteins, such as CP190 and Mod(mdg4), contain BTB domains, and they colocalize in different combinations and levels of occupancy at architectural protein binding sites (APBSs) ([@R55]). Several studies have suggested that interactions among GAF, Psq, and Pc involve the BTB domains of GAF and Psq ([@R17]; [@R45]). Therefore, it has been assumed that the BTB-containing Psq is responsible for the recruitment of Pc to GAGA sequences. However, this notion is at odds with earlier findings showing that the presence of a BTB domain inhibits DNA binding ([@R2]). Thus, the role of the BTB domain in the function of sequence-specific transcription factors and in the recruitment of PcG complexes remains unresolved. Given the expanding role of BTB domain-containing proteins and the PcG machinery in chromatin structure and cancer ([@R50]), it is important to characterize how variants lacking the BTB domain act in transcriptional regulation and cell differentiation.

Here, we characterize the *in vivo* function of Psq isoforms containing or lacking the BTB domain, their differential chromatin binding, and their associated long-range chromatin contacts using chromatin immunoprecipitation sequencing (ChIP-seq) and chromosome conformation capture (3C) coupled with sequencing combined with chromatin immunoprecipitation (HiChIP). We found that Psq^L^ colocalizes with Suppressor of Hairy wing (Su(Hw)) and other architectural proteins at sequences classically defined as insulators. In contrast to what was previously assumed, Psq^S^, rather than BTB-containing Psq^L^, colocalizes with GAF and Pc at enhancer elements and may therefore be responsible for the classical GAGA binding function assigned to the Psq protein. HiChIP analysis identifies two types of Pc-associated interactions. The first corresponds to Pc loops established by high-frequency point-to-point interactions between anchors containing Psq^S^. The second type corresponds to contacts between large, repressive Pc domains that form broad interactions similar to those mediated by B compartmental domains. To analyze the functional role of these interactions, we then examined changes in the 3D organization of chromatin during the ecdysone-inducible response and show that Psq^S^-bound enhancers undergo dramatic changes in their contacts with the promoters of ecdysone-induced genes. These findings suggest distinct roles for Psq isoforms containing or lacking the BTB domain in Pc function and 3D chromatin architecture in response to developmental cues elicited by ecdysone.

RESULTS {#S2}
=======

Psq Isoforms Have Distinct Roles {#S3}
--------------------------------

To analyze the role of the BTB domain in the function of Psq isoforms and their ability to bind to GAGA sites *in vivo*, we first examined isoform-specific functions by analyzing their effects on tumorigenesis. The *psq* gene encodes 12 annotated transcripts generated by alternative use of promoters ([Figure S1A](#SD1){ref-type="supplementary-material"}). Previous work using northern blot analyses concluded that only isoforms lacking the BTB domain are expressed in the larval imaginal tissues ([@R18]; [@R57]). Although the phenotypic classes of *psq* alleles were initially attributed to defects in the long or short transcripts encoding Psq isoforms containing (Psq^L^) or lacking (Psq^S^) the BTB domain, subsequent studies indicate an intricate relationship between Psq isoforms and complex roles in epigenetic silencing in conjunction with Pc ([@R14]; [@R20]). Since Psq^S^ is fully contained within the long Psq^L^ isoform ([Figure S1A](#SD1){ref-type="supplementary-material"}), we tested their function *in vivo* using isoform-specific transgenes driven by the yeast Gal4 upstream activating sequence (*UAS-Psq^L^* and *UAS-Psq^S^*). Because mutations that drive Gal4-mediated overexpression of the *psq* gene (psq^GS88A8^) ([Figure S1A](#SD1){ref-type="supplementary-material"}) can cause tumorigenesis when combined with another oncogene ([@R14]), we assayed each isoform for its ability to trigger tissue overgrowth and tumors when coexpressed with a Notch ligand Delta (UAS-Dl) transgene in the growing eye imaginal disc with the help of the ey-Gal4 driver ([Figure S1B](#SD1){ref-type="supplementary-material"}). Although Psq^L^ overexpression efficiently drove tissue overgrowth/tumor, Psq^S^ did not ([Figures S1B](#SD1){ref-type="supplementary-material"} and [S1C](#SD1){ref-type="supplementary-material"}). This observation supports the notion that tumor formation is driven by mis-expression of isoforms containing both the BTB and the Psq HTH domains. Because point mutations within a conserved amino acid in the HTH DNA binding region of *psq* reverse tumorigenesis by the gain-of-function *psq^GS88A8^* mutation ([Figure S1B](#SD1){ref-type="supplementary-material"}), we hypothesize that the tumor-promoting role of Psq^L^ may rely on its ability to interact with DNA. However, binding of the full-length Psq proteins to DNA remains undefined. Moreover, the Psq^S^ isoform uses the HTH DNA binding domain, and *in vitro* studies have shown that Psq proteins containing this region can selectively bind GAGA sequences ([@R26]). Nevertheless, Psq^S^ does not drive tissue overgrowth in the transgenic overexpression assay. We therefore hypothesize that the presence of the BTB domain might regulate the affinity, specificity, or ability of the HTH region to interact with DNA, consistent with earlier observations ([@R26]; [@R2]). These results indicate that the presence or absence of the BTB domain in the Psq protein has functional consequences.

We next examined the genome-wide association of Psq^L^ and Psq^S^ with DNA by first raising two antibodies: a BTB isoform-specific antibody (aa 92--106, Psq^L^ antibody) and an antibody that recognizes all Psq isoforms (aa 453--552, Psq^tot^ antibody) ([Figure S1A](#SD1){ref-type="supplementary-material"}). The specificity of Psq^tot^ antisera was demonstrated by labeling larval wing imaginal discs expressing an interference RNA transgene to silence the *psq* gene (*Psq-IR*) ([@R8]) using the *MS1096-Gal4* driver ([Figure S1D](#SD1){ref-type="supplementary-material"}). Because the levels of the detected endogenous Psq^L^ have little consistency ([Figure S1D](#SD1){ref-type="supplementary-material"}) with those of earlier analyses ([@R18]), we tested the Psq^L^-specific antisera in control larval imaginal discs expressing the *UAS-Psq^L^* transgene in a defined stripe of cells in the wing disc using *dpp-Gal4* ([Figure S1D](#SD1){ref-type="supplementary-material"}). We additionally tested the specificity of the antibodies generated through immunoprecipitation (IP) ([Figure S1E](#SD1){ref-type="supplementary-material"}). Psq^L^ antibody only immunoprecipitates a band of 150 kDa corresponding to the BTB-containing protein. Moreover, Psq^tot^ detects both isoforms of Psq: the 75 kDa Psq^S^ and the 150 kDa Psq^L^ ([Figure S1E](#SD1){ref-type="supplementary-material"}). Having demonstrated the specificity of the two Psq antibodies, we then used them to study the genome-wide distribution of the different Psq isoforms to understand the functional role of the BTB domain.

BTB-Containing Psq^L^ Colocalizes with Su(Hw)-Associated Architectural Proteins {#S4}
-------------------------------------------------------------------------------

To assess the impact of the BTB domain on DNA binding, we used the Psq^L^ and Psq^tot^ antibodies to examine the distribution of Psq^L^ and Psq^S^ by ChIP-seq in *Drosophila* Kc167 cells ([Table S1](#SD1){ref-type="supplementary-material"}), which express both Psq isoforms ([Figure S1E](#SD1){ref-type="supplementary-material"}). By combining both datasets, we detect 10,478 Psq peaks. Because of the specificity of the Psq^L^ antibody, we assumed that peaks detected by the Psq^tot^ antibody, but not detected by Psq^L^, could be used to identify Psq^S^ binding sites ([Figure 1A](#F1){ref-type="fig"}). Using this strategy, 6,386 (61%) peaks were identified as candidate binding sites of the Psq^S^ isoform ([Figure 1B](#F1){ref-type="fig"}). We detect 1,962 Psq^L^ peaks that showed a ChIP-seq signal with the Psq^L^ antibody and no signal with the Psq^tot^ antibody ([Figure S2A](#SD1){ref-type="supplementary-material"}). The MD453--552 epitope used to prepare the Psq^tot^ antibody, which is present in the amino-terminal part of Psq^S^ and within the Psq^L^ isoform ([Figure S1A](#SD1){ref-type="supplementary-material"}), could be occluded under native conditions by Psq-interacting proteins. If this is the case, the Psq^L^-specific peaks could represent complexes lacking Psq^S^, which could have more exposed epitopes recognized by the Psq^tot^ antibody. In support of this, previous ChIP-seq experiments using the Organic ChIP-seq method and antibodies similar to Psq^tot^ failed to detect these Psq^L^ sites ([Figure S2A](#SD1){ref-type="supplementary-material"}; [@R23]). We also identified a third category of peaks that were strongly enriched with both antibodies. These peaks either represent sites strongly bound by Psq^L^ alone or by a combination of Psq^L^ and Psq^S^ (n = 2,130). When analyzing these peaks (as described later), we found similarities to both Psq^L^ and Psq^S^ binding sites; thus, we named the peaks detected by both antibodies Psq^L&S^.

We next performed motif analysis at Psq^L^-specific sites. These sites are highly enriched in the Su(Hw) binding motif. Approximately 91% of Psq^L^ binding sites contain this motif, while only 1% exclusively contain the GAGA motif ([Figure 1C](#F1){ref-type="fig"}). This observation is consistent with experiments suggesting that the BTB domain inhibits the interactions of the associated DNA binding domain with DNA ([@R26]). Only 4% of Psq^S^ peaks overlap the Su(Hw) motif, indicating that the two Psq isoforms recognize different sites in the genome. We identified motif locations using q \< 0.05; therefore, we tested whether the observed overlap could be explained by low-significance motifs. We found that 85% and 66% of Psq^L^ sites overlap Su(Hw) motif positions called at q \< 0.01 and q \< 0.001, respectively ([Figure 1D](#F1){ref-type="fig"}). The prevalent presence of Su(Hw) motifs at Psq^L^ binding sites suggests an association between Psq^L^ and architectural proteins, some of which also contain BTB domains, including CP190 and Mod(mdg4)2.2 ([@R16]). To explore the possibility that Psq^L^ colocalizes with architectural proteins, we compared its genomic distribution with that of 13 architectural proteins using published ChIP-seq data in Kc167 cells (see [Key Resources Table](#T1){ref-type="table"}). We plotted the signal of each feature across a 2-kb region surrounding the Psq^L^ peak summits and identified distinct patterns of binding using k-means clustering. We found, as expected, that Psq^L^ colocalizes with Su(Hw) ([Figure 1E](#F1){ref-type="fig"}). There is also enrichment of BTB-containing proteins CP190 and Mod(mdg4)2.2 and weak enrichment of CTCF and Rad21 ([Figure 1E](#F1){ref-type="fig"}). In contrast, Psq^L^ does not colocalize with other architectural proteins, such as BEAF-32, Dref, Cap-H2, Chromator, Z4, Nup98, or L3mbt, suggesting that Psq^L^ is not present at high-occupancy APBSs ([Figure 1E](#F1){ref-type="fig"}). We also performed ChIP-seq for imitation SWI (ISWI) and found that Psq^L^ sites are enriched for this ATP-dependent nucleosome-remodeling factor ([Figure 1E](#F1){ref-type="fig"}). To test whether the colocalization between Psq^L^ and Mod(mdg4)2.2 may result from direct interactions between these proteins through their BTB domains, we performed coimmunoprecipitation (coIP) experiments using antibodies for these two proteins. We detect Mod(mdg4)2.2 in material immunoprecipitated with the Psq^L^ antibody ([Figure 1F](#F1){ref-type="fig"}), as well as Psq^L^ in material immunoprecipitated with the Mod(mdg4)2.2 antibody ([Figure 1G](#F1){ref-type="fig"}), indicating that these two BTB-containing proteins interact with each other. Pc, GAF, and active or repressive histone modifications are largely absent from Psq^L^ sites ([Figure 1E](#F1){ref-type="fig"}). In agreement with this, Psq^L^ is absent from the self-transcribing active regulatory region sequencing (STARR-seq) sites defining housekeeping (hkCP) and developmental (dCP) enhancers ([@R60]; [Figure 1E](#F1){ref-type="fig"}).

Psq Isoforms Lacking the BTB Domain Colocalize with GAF and Pc at Enhancer Elements Containing GAGA Motifs {#S5}
----------------------------------------------------------------------------------------------------------

We next analyzed the enrichment of DNA binding motifs at ChIP-seq peaks for the Psq^S^ isoform. The most significant motif corresponds to GAGA ([Figure 2A](#F2){ref-type="fig"}), as described in native ChIP-seq experiments using an antibody recognizing all Psq isoforms ([@R23]). Approximately 37% of Psq^S^ peaks contain the GAGA motif within a 200 bp region surrounding the peak summit ([Figure S2B](#SD1){ref-type="supplementary-material"}). This enrichment is higher than expected for random genomic locations and is similar to that of ChIP-seq peaks for the GAF protein ([Figure S2B](#SD1){ref-type="supplementary-material"}). Stronger Psq^S^ peaks are more likely to overlap the GAGA motif ([Figure 2B](#F2){ref-type="fig"}, blue line). Because we saw a GAF ChIP-seq signal at Psq^S^ binding sites, in line with enrichment of the GAGA motif ([Figure 2C](#F2){ref-type="fig"}), we asked whether all GAF binding sites are also bound by Psq^S^. To test this hypothesis, we examined the Psq ChIP-seq signal across all detected GAF binding sites. We found that nearly half of GAF peaks show enrichment of Psq, most of which corresponds to the Psq^S^ isoform ([Figure S2C](#SD1){ref-type="supplementary-material"}). Psq has been proposed to interact with GAF through the BTB domain ([@R45]). However, the presence of Psq^S^, which lacks the BTB domain, at GAF sites suggests that the interaction may involve different domains of these proteins. The occurrence of Psq^S^ co-incides with the strongest GAF signal, and Psq^S^ is only present at GAF sites that are enriched for Pc ([Figure S2C](#SD1){ref-type="supplementary-material"}).

We then examined the colocalization of Psq^S^ binding sites with those of other transcription factors or histone modifications. As described earlier, we plotted the signal of each feature across a 2-kb region surrounding the Psq^S^ peak summits and identified distinct patterns of binding using k-means clustering. We detect ChIP-seq signals corresponding to Pc at nearly all Psq^S^ peaks, and vice versa ([Figures 2D](#F2){ref-type="fig"} and [S2D](#SD1){ref-type="supplementary-material"}). We examined the relative binding strength of these two proteins and found a correlation between Psq^S^ and Pc ChIP-seq signal ([Figure S2E](#SD1){ref-type="supplementary-material"}). This indicates that Psq^S^ colocalizes with Pc genome-wide and overlaps with GAF ([Figures 2D](#F2){ref-type="fig"} and [S2D](#SD1){ref-type="supplementary-material"}). In addition to its presence at narrow peaks lacking H3K27me3 ([Figure 2C](#F2){ref-type="fig"}), Pc is distributed in broad domains termed Pc domains ([@R43]) that contain H3K27me3 signal. These domains correspond to cluster 1 with broad enrichment of Pc ([Figure 2D](#F2){ref-type="fig"}), which may correspond to regions containing the classical PREs ([@R1]). Psq^S^ is present at these broad Pc domains, including several PcG-silenced Hox genes such as *deformed* (*Dfd*), *Sex combs reduced* (*scr*), and *Antennapedia* (*Antp*) ([Figure S2F](#SD1){ref-type="supplementary-material"}). These regions contain high levels of H3K27me3 and Pc, with most sites of Psq^S^ and GAF colocalizing at the summits of Pc peaks ([Figure S2F](#SD1){ref-type="supplementary-material"}). We found that Psq^S^ sites at repressive Pc domains represent a small fraction of the total, and most Psq^S^ sites coincide with narrow Pc peaks containing active histone modifications ([Figure 2D](#F2){ref-type="fig"}). For example, the *sprouty* (*spry*) and *eIF5B* genes are present in an active histone H3 lysine 27 acetylation (H3K27ac)-rich chromatin domain, where Pc and GAF colocalize at the summits of Psq^S^ peaks ([Figure 2C](#F2){ref-type="fig"}). Psq^S^ sites overlapping with Pc and H3K27ac are also enriched in CREB-binding protein (CBP), which is typically found at enhancers ([Figures 2C](#F2){ref-type="fig"} and [2D](#F2){ref-type="fig"}). We therefore tested whether Psq^S^ is enriched at Pleiohomeotic (Pho)-occupied enhancers that were previously annotated in embryos ([@R12]) and found great enrichment compared with random regions ([Figure S2G](#SD1){ref-type="supplementary-material"}). We also tested whether Psq^S^-bound regions correspond to enhancers by examining STARR-seq signal for hkCP and dCP enhancers ([@R60]). Cluster 2 is enriched for dCP enhancer signal, whereas cluster 3 is enriched for hkCP enhancer signal ([Figure 2D](#F2){ref-type="fig"}). Psq^S^ sites that overlap hkCP enhancers are enriched in histone H3 lysine 4 trimethylation (H3K4me3), whereas those overlapping dCP enhancers are enriched in histone H3 lysine 4 monomethylation (H3K4me1), which is consistent with previous results for these two types of enhancers ([@R6])([Figure S2H](#SD1){ref-type="supplementary-material"}). Cluster 4 represents Psq^S^ binding sites that lack histone modifications characteristic of enhancers but contain low levels of CBP and Pc ([Figure 2D](#F2){ref-type="fig"}). These results reveal that the Psq^S^ isoform is enriched at enhancer sites that contain the GAGA motif and suggest that Psq^S^ binds to DNA through these sequences.

Overall, these data indicate that while Psq^S^ is present at sites bound by GAF, CBP, and Pc, Psq^L^ colocalizes with Su(Hw), CP190, Mod(mdg4)2.2, and ISWI, suggesting different roles for the two isoforms. In addition, we examined Psq^L&S^ peaks and found examples in which both GAF and Su(Hw) overlap these binding sites ([Figure 2E](#F2){ref-type="fig"}). Analysis of ChIP-seq data at these undetermined Psq peaks found enrichment of GAF, Pc, CBP, and STARR-seq enhancers, which is similar to what we found for Psq^S^ ([Figure 2F](#F2){ref-type="fig"}). We also found enrichment for CP190 and Mod(mdg4)2.2, which is similar to what we found for Psq^L^ ([Figure 2F](#F2){ref-type="fig"}). We also detect a slight enrichment of Su(Hw), although not as strongly as at Psq^L^ sites (compare [Figure 2F](#F2){ref-type="fig"} with [Figure S2H](#SD1){ref-type="supplementary-material"}). Hence, Psq^L&S^ peaks exhibit characteristics of both Psq^L^ and Psq^S^ binding sites and are thus likely bound by both.

Psq^S^ Colocalizes with Pc at Chromatin Loops Distinct from Repressive Pc Domains {#S6}
---------------------------------------------------------------------------------

Because the Psq^S^ isoform is responsible for GAGA binding, we wondered whether Psq^S^ regulates Pc at chromatin loops. Computational annotation of strong point-to-point interactions in *Drosophila* Kc167 cells has identified 458 potential loops ([@R6]). These structures have also been annotated visually, resulting in the identification of 120 loops ([@R11]). We found that Pc overlaps 30% of loop anchors annotated computationally and 68% of those annotated visually. Psq^S^ peaks overlap 21% and 53% of these two classes of loop anchors, respectively, whereas Psq^L^ only overlaps 3% and 5%. These loop anchors have sharp peaks of Psq^S^ and sharp peaks of Pc instead of the broad Pc signal representative of repressive Pc domains ([Figures 3A](#F3){ref-type="fig"} and [S3A](#SD1){ref-type="supplementary-material"}). Although overlap of loops with Pc ChIP-seq has been reported ([@R11]; [@R32]), it is unclear whether Pc directly participates in the establishment of these loops. Therefore, we performed HiChIP using a Pc antibody (see [Table S2](#SD1){ref-type="supplementary-material"} for quality controls and statistics of the Pc HiChIP libraries) and used these data to examine Pc-bound loops ([Figure S3B](#SD1){ref-type="supplementary-material"}, top right). These loops represent strong or frequent interactions compared with surrounding regions as seen by metaplot analysis of Hi-C data ([Figure 3B](#F3){ref-type="fig"}, left) and are enriched in Pc HiChIP data ([Figure 3B](#F3){ref-type="fig"}, right). To determine the chromatin state of Pc loop anchors identified by HiChIP, we plotted active and inactive marks around the Pc ChIP-seq summit found at loop anchors. We found high levels of H3K27me3 in the surrounding region but a dip precisely at the loop anchor ([Figure 3C](#F3){ref-type="fig"}). Instead of H3K27me3, the Pc loop anchor precisely corresponds to a peak of H3K27ac ([Figure 3C](#F3){ref-type="fig"}). Because there is high overlap between Pc and Psq^S^ peaks in ChIP-seq data ([Figure 2D](#F2){ref-type="fig"}), we examined whether loop anchors identified by Pc HiChIP are enriched in Psq^S^. We detect enrichment of the GAF, CBP, ISWI, and Psq^S^ signal at these anchors ([Figure S3C](#SD1){ref-type="supplementary-material"}). To confirm that Psq^S^ is directly associated with Pc loops, we then performed HiChIP using the Psq^tot^ antibody (see [Table S3](#SD1){ref-type="supplementary-material"} for quality controls and statistics of Psq HiChIP libraries) and found that Pc loops are enriched in Psq HiChIP signal ([Figure S3B](#SD1){ref-type="supplementary-material"}, bottom left, and [Figure 3D](#F3){ref-type="fig"}). These data suggest that strong point-to-point Pc interactions detected by HiChIP represent loops anchored by sites of active chromatin cobound by Psq^S^, GAF, CBP, ISWI, and H3K27ac ([Figure 3A](#F3){ref-type="fig"}).

To investigate chromatin organization in the context of Pc-repressed chromatin, we identified domains in which Pc was enriched in regions of a minimum length of 10 kb (see [STAR Methods](#S10){ref-type="sec"}). We examined differences between large Pc domains and inactive B compartmental domains ([@R40]). We found that although B compartmental domains are enriched in H3K27me3 versus H3K27ac, Pc domains contain higher levels of H3K27me3 than standard B domains ([Figure S3D](#SD1){ref-type="supplementary-material"}; see also [Figure S3A](#SD1){ref-type="supplementary-material"}). Pc HiChIP data enriched Pc domains, but not B compartmental domains, when compared with Hi-C ([Figure S3E](#SD1){ref-type="supplementary-material"}). In contrast, Psq HiChIP did not enrich these repressive Pc domains ([Figure S3F](#SD1){ref-type="supplementary-material"}), indicating that repressive Pc domain interactions are distinct from Psq/Pc looping interactions. By examining interactions from Hi-C data at Pc domains, we found that Pc domains interact more with each other than with other inactive B compartmental domains ([Figure 3E](#F3){ref-type="fig"}, black versus green box). We examined more closely a Pc domain containing different levels of Pc and H3K27me3, and we observed a correlation between interaction frequency and levels of Pc and H3K27me3 ([Figure 3F](#F3){ref-type="fig"}). This suggests that Pc domains associate with other Pc domains preferentially over other inactive chromatin, which is in agreement with studies in *Drosophila* embryos ([@R32]). To test this genome-wide, we classified interactions as those with repressive Pc domains on both sides (Pc-Pc), those with a Pc domain on one side and a B compartmental domain on the other (Pc-B), or those with B compartmental domains on both sides (B-B). We found that Pc-Pc interactions are stronger than Pc-B interactions and B-B interactions ([Figure 3G](#F3){ref-type="fig"}). Pc-B interactions were similar to B-B interactions, indicating that Pc domains are not prevented from interacting with other B compartmental domains but that they interact more frequently with other Pc domains ([Figure 3G](#F3){ref-type="fig"}). Altogether, these results suggest the existence of two types of Pc-mediated chromatin organization: those resulting from interactions between broad repressive Pc domains, which are similar to compartmental interactions, and those resulting from point-to-point interactions associated with Psq^S^ and visible as intense punctate signals in Hi-C heatmaps ([Figure 3A](#F3){ref-type="fig"}).

A Role for Steroid Hormone 20-Hydroxyecdysone in Psq Chromatin Loops {#S7}
--------------------------------------------------------------------

Given that narrow peaks of Pc overlapping with Psq^S^ are present at dCP enhancers defined by STARR-seq ([Figure 2D](#F2){ref-type="fig"}, dCP), we wondered whether Psq^S^ and Pc are involved in dCP transcriptional responses via enhancer-promoter interactions. To this end, we examined changes in Psq and Pc interactions during the response to the steroid hormone 20-hydroxyecdysone (20-HE) ([@R7]). Treatment of *Drosophila* macrophage-like Kc167 cells with 20-HE triggers their differentiation, recapitulating events occurring during metamorphosis ([@R56]). Visual inspection of ChIP-seq data indicates the presence of Psq^S^ peaks at genes induced by 20-HE, suggesting that Psq may be involved in the response to this hormone. This hypothesis is supported by colocalization between Psq^S^ and nucleoporin Nup98 ([Figure S2H](#SD1){ref-type="supplementary-material"}), which is involved in the ecdysone response ([@R33]). The expression of the ecdysone receptor (*EcR*) gene is induced by 20-HE and provides an autoregulatory loop that increases the level of receptor protein available for ligand binding and target-gene activation ([@R22]; [@R38]). We therefore examined the genome-wide distribution of Psq, Pc, and EcR binding sites by ChIP-seq in Kc167 cells ([Table S1](#SD1){ref-type="supplementary-material"}). We identified 845 loci to which EcR binds under normal conditions, with strong enrichment of Psq^S^ and Psq^L^ ([Figure 4A](#F4){ref-type="fig"}). EcR binding sites in cluster 1 overlap with sites containing Psq^S^ or Psq^L&S^, which are enriched for GAF, Pc, CBP, hkCP, and dCP enhancers, and active histone modifications ([Figure 4A](#F4){ref-type="fig"} and example in [Figure S4A](#SD1){ref-type="supplementary-material"}). EcR binding sites in cluster 2 overlap with the Psq^L^ isoform, Su(Hw), CP190, and Mod(mdg4)2.2 ([Figure 4A](#F4){ref-type="fig"} and example in [Figure S4B](#SD1){ref-type="supplementary-material"}).

We hypothesize that the assembly of multiple simultaneous interactions of Psq^S^, EcR, and Pc at ecdysone-responsive genes might correlate with their transcriptional response. We thus performed ChIP-seq for Psq^L^, Psq^tot^, Pc, and EcR after treatment with 0.5 μM 20-HE for 3 h ([@R58]). The well-studied ecdysone-inducible *Eip75B* gene encodes different mRNA variants with different hormone sensitivity. EcR binding significantly increases at a region within the locus after 20-HE treatment ([Figure 4B](#F4){ref-type="fig"}, purple box) accompanied by enhanced signal corresponding to Psq^S^ ([Figure 4B](#F4){ref-type="fig"}). The increase in EcR and Psq^S^ occurs upstream of *Eip75B-RA*, which is the isoform with the highest response to the hormone ([Figure S4C](#SD1){ref-type="supplementary-material"}). We then used MAnorm ([@R46]) to compare Psq^S^ peaks obtained before and after genome-wide treatment with the hormone. This analysis identified 35 peaks in which Psq^S^ binding increases after 20-HE treatment (Psq^S^-inducible peaks) ([Figure 4B](#F4){ref-type="fig"}). We found a similar number of peaks, 45 and 50, corresponding to Psq^L^ and Psq^L&S^ sites, respectively, that increase after ecdysone treatment. Genes that overlap with hormone-inducible Psq^S^ peaks (not Psq^L^-containing peaks) were more likely to have increased expression after 20-HE treatment than genes that overlap with unaltered peaks ([Figure 4C](#F4){ref-type="fig"}). We saw no difference for genes that overlap any other category of Psq peaks ([Figure 4C](#F4){ref-type="fig"}). Because the total amount of Psq mRNA in the cell does not change significantly after 20-HE treatment ([Figure S4D](#SD1){ref-type="supplementary-material"}), we envision that hormone treatment facilitates Psq binding or recruitment to these ecdysone-induced genes. Some ecdysone-induced genes, such as *CG44004* or *Vrille* ([Figures 4D](#F4){ref-type="fig"} and [4E](#F4){ref-type="fig"}), do not show changes in Psq^S^, and 11 of 35 Psq^S^-inducible peaks are not close to known ecdysone-induced genes. This raises the possibility that Psq^S^ might regulate the ecdysone response through 3D chromatin changes and these peaks may represent distal regulatory elements. Therefore, we next studied Psq-directed changes in chromatin architecture in response to ecdysone using HiChIP.

Ecdysone Induces the Establishment of Enhancer-Promoter Interactions Bound by Psq^S^ and Pc {#S8}
-------------------------------------------------------------------------------------------

Enhancers regulate gene expression through long-range chromatin interactions with promoters. We thus asked whether Psq is involved in these interactions. First, we identified 180,058 active enhancer-promoter interactions using previously published H3K27ac HiChIP data ([@R40]) in which one interaction anchor overlaps a promoter while the other overlaps a STARR-seq enhancer. Next, we examined which Psq isoform is most enriched at these enhancer-promoter interaction anchors. Of 94,483 enhancer-promoter interactions that are bound by Psq, we found that only 3% correspond to the Psq^L^ isoform, whereas 76% correspond to the Psq^S^ isoform and 21% correspond to Psq^L&S^ ([Figure 5A](#F5){ref-type="fig"}). This is consistent with our finding that Psq^S^ binds to elements with enhancer potential as determined by STARR-seq ([Figure 2D](#F2){ref-type="fig"}) and supports the conclusion that enhancer elements bound by the GAGA-motif-binding Psq^S^ protein may participate in long-range interactions with target promoters.

We analyzed the presence of Psq^S^ in enhancer-promoter interaction anchors using Psq^S^ HiChIP data and found enrichment of interaction signals at enhancer-promoter contact points compared with surrounding regions ([Figure 5B](#F5){ref-type="fig"}). Interactions detected using Hi-C data are also enriched at enhancer-promoter contacts identified using Psq HiChIP ([Figure S5A](#SD1){ref-type="supplementary-material"}). We therefore hypothesized that ecdysone treatment may alter gene expression through changes to a subset of these interactions. Using STARR-seq data obtained in ecdysone-treated cells to select for enhancers involved in the ecdysone response ([@R48]), we tested the overlap of each Psq isoform with ecdysone-induced enhancers and found that these enhancers are enriched in Psq^S^ ([Figure 5C](#F5){ref-type="fig"}). Thus, although half of EcR binding sites are co-occupied by Psq^L^ ([Figure 4A](#F4){ref-type="fig"}), EcR sites overlapping Psq^S^ are more likely to be functionally relevant ecdysone-induced enhancers. However, there is no change in Psq, Pc, or EcR at ecdysone enhancers upon ecdysone treatment ([Figure S5B](#SD1){ref-type="supplementary-material"}). Because of this overlap between ecdysone-induced enhancers and Psq^S^, and to obtain 1-kb resolution data necessary to accurately observe changes in 3D chromatin organization, we performed HiChIP for Psq^S^ in cells treated with 20-HE (see [Table S4](#SD1){ref-type="supplementary-material"} for quality control and statistics). We then compared this information to HiChIP data obtained in untreated cells. Example loci show the existence of many sites with a higher interaction signal after 20-HE treatment ([Figure 5D](#F5){ref-type="fig"}, bottom left) compared with the control ([Figure 5D](#F5){ref-type="fig"}, top right). These sites with an increased signal correspond to ecdysone enhancers identified by STARR-seq signal after ecdysone treatment ([Figure 5D](#F5){ref-type="fig"}). We then tested whether ecdysone treatment changes chromatin interactions, specifically between ecdysone enhancers and ecdysone-regulated genes. We took ecdysone enhancers within 50 kb of genes differentially expressed after ecdysone treatment and performed a 2D metaplot analysis with the Psq HiChIP data. In control cells, there is little to no signal connecting ecdysone enhancers to transcription start sites (TSSs) of ecdysone-induced genes ([Figure 5E](#F5){ref-type="fig"}, top right). After 20-HE treatment, the HiChIP signal is stronger between these sequences ([Figure 5E](#F5){ref-type="fig"}, bottom left). This enrichment cannot be explained by different IP efficiencies before and after ecdysone, because the average ChIP-seq signal of Psq^S^ is the same under both conditions at these interaction anchors ([Figure S5C](#SD1){ref-type="supplementary-material"}; see also [Figure 5D](#F5){ref-type="fig"}). Of the 180,058 potential enhancer-promoter interactions examined in [Figure 5A](#F5){ref-type="fig"}, 7,417 of them are occupied by EcR on at least one anchor. We then examined enhancer-promoter contacts containing EcR for changes in interaction frequency after ecdysone treatment using Hi-C and Psq HiChIP data. We found little to no HiChIP signal at these sites in the control and increased interactions upon ecdysone treatment ([Figures S5D](#SD1){ref-type="supplementary-material"}--[S5G](#SD1){ref-type="supplementary-material"}). This indicates that ecdysone treatment leads to changes in chromatin 3D organization between EcR-bound regions. However, no difference in Pc signal was observed at these interaction anchors before and after ecdysone treatment ([Figure S5H](#SD1){ref-type="supplementary-material"}). Thus, ecdysone treatment triggers chromatin interactions at Psq^S^-bound enhancers without changes in Pc. Because we found that ecdysone treatment induces enhancer-promoter interactions bound by Psq^S^ and Pc, we analyzed possible changes in the intense puncta representing Pc loops in control cells ([@R11]) (see [Figure 3A](#F3){ref-type="fig"}). We found no change to these pre-existing Pc/Psq^S^ loops, indicating that changes in 3D organization are specific to ecdysone enhancers without changes to Pc/Psq^S^ loops manifested by strong puncta in Hi-C data ([Figure S5I](#SD1){ref-type="supplementary-material"}). This provides evidence that ecdysone regulates gene expression by changing the 3D organization of chromatin to increase the frequency of interactions between enhancers and promoters bound by Psq^S^ and Pc.

DISCUSSION {#S9}
==========

The BTB domain of human PLZF, Bcl-6, and *Drosophila* Psq have been shown to contribute to the oncogenic roles of these proteins ([@R14], and citations therein). Most BTB-containing transcription factors also encode isoforms that lack the BTB domain ([@R24]) and the role of these short isoforms is uncertain. Here we show that different isoforms of Psq appear to play different roles in nuclear function, which may explain their opposing roles in tumorigenesis ascribed to the gene. We show that the BTB-containing Psq^L^ isoform colocalizes with a specific class of architectural proteins that includes Su(Hw), CP190, and Mod(mdg4)2.2. In contrast, the Psq^S^ isoform, which lacks the BTB domain, colocalizes with GAF and Pc at dCP enhancers and is mainly associated with active chromatin states. Therefore, Psq^S^ appears to contribute to enhancer function, whereas Psq^L^ is an architectural protein that binds to sequences that have insulator function. How these two isoforms display different genomic distributions while sharing the same DNA binding domain is unclear. However, based on previous findings ([@R26]), we can speculate that the conformation adopted by the protein in the presence of the BTB-interaction domain might inhibit its direct binding to DNA. In addition, the two isoforms coincide in regions in which both Pc and architectural proteins are found. This may explain the reported involvement of Psq^L^ in the recruitment of PcG proteins to chromatin ([@R20]), where it might act with the help of other architectural proteins. In addition to its canonical role, Pc is found, together with Psq^S^, ISWI, GAF, and CBP, in regions containing H3K27ac and previously characterized experimentally as hkCP or dCP enhancers. These findings, suggesting an association of Pc with active enhancers, agree with previous observations showing that PRC1 can be recruited to active genes by the cohesin complex, where it affects phosphorylation of Pol II and Spt5 occupancy ([@R41]; [@R35]).

H3K27me3 is present in the genome of Kc167 cells at very high levels in Pc-repressed domains such as *Hox* genes. The rest of the genome containing silenced genes in Kc167 cells has low but significant levels of H3K27me3 that represent B compartment sequences ([@R40]). Pc HiChIP analysis provides insights into the dual role of Pc in regulating chromatin organization. Classical Pc-repressed domains interact with each other and with other B compartments with a frequency that correlates with the amount of H3K27me3 present in these compartments. Distinct from these interactions, Pc also forms punctate point-to-point contacts. Two types of loops, defined as puncta of an intense signal in Hi-C heatmaps, have been identified when analyzing changes in 3D organization during *Drosophila* embryonic development ([@R32]). These loops were classified as active loops containing H3K27ac, Zelda, and Pol II at their anchors or as Pc loops bound by GAF. Zelda loops are absent from Kc167 cells ([@R32]). Like Pc loop anchors observed in embryos, loops represented by puncta in Hi-C heatmaps of Kc167 cells are located within regions enriched in H3K27me3 ([@R6]; [@R11]). However, we found that the center of these sites in Kc167 cells is depleted of H3K27me3 and enriched in H3K27ac. The exact roles of H3K27ac, Pc, Psq^S^, and GAF found at these loop anchors are unknown, but we speculate that maintaining a localized active chromatin state may be important for the binding of these proteins and the establishment of these loops. These results suggest a dual and context-dependent function of regulatory elements and agree with previous studies showing that dCP enhancers can act as PREs, and vice versa, during *Drosophila* embryogenesis ([@R12]).

Analysis of the distribution of sites containing Pc and Psq^S^ in the genome also uncovered enrichment of these proteins around ecdysone-inducible genes, although most EcR, Pc, and Psq^S^ peaks do not change significantly after ecdysone treatment. This is consistent with previous observations indicating that EcR does not change at most enhancers induced by ecdysone ([@R48]). Results from Psq^S^ HiChIP experiments in control and ecdysone-treated cells suggest that hormone treatment leads to the establishment of new ecdysone-induced enhancer-promoter interactions without changes to pre-established Pc/Psq^S^ loops. Early genes directly activated by ecdysone are paused before induction, and their expression is regulated at the level of Pol II release from promoter-proximal pausing ([@R21]; [@R30]). This suggests that activation of early gene expression by ecdysone requires the establishment of new enhancer-promoter interactions. The possible involvement of Psq^S^ and Pc in the establishment of these interaction networks in the *Drosophila* embryo will be an interesting topic for future analyses.

STAR★METHODS {#S10}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S11}
---------------------------------------

Further information and requests for resources and reagents should be directed and will be fulfilled by the Lead Contact, Maria Dominguez (<m.dominguez@umh.es>, Phone: +34 965 91 9390).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S12}
--------------------------------------

### *Drosophila* Cell Lines {#S13}

Kc167 cells derived from a *Drosophila melanogaster* female embryo at the dorsal closure stage were obtained from the *Drosophila* Genomics Resource Center. Cells were grown at 25°C in Hyclone SFX insect culture media (GE Healthcare).

### *Drosophila* Husbandry and Strains {#S14}

Flies were reared in vials containing cornmeal medium. Flies were collected under CO~2~-induced anesthesia and housed at a density of 30 female flies per vial. All flies were kept in a humidified, temperature-controlled incubator with 12 h on/off light cycle at 25°C.A detailed description of the *Drosophila* stocks and transgenic flies used in this study can be found at <http://flybase.org/> (*MS1096-Gal4* and *Dpp-Gal4*) or at VDRC RNAi stock (Psq-IR), <https://stockcenter.vdrc.at/control/main>. Strain *UAS-Psq-L* was produced in the laboratory of Dr. Maria Dominguez.

METHOD DETAILS {#S15}
--------------

### Immunofluorescence and microscopy analysis {#S16}

Third instar wing imaginal discs were fixed and stained using standard procedures and the following primary antibodies. Psq^tot^ antibody (Rabbit 1:200) against the common epitope for both isoforms encompassing residues 453-552 of the long Psq isoform; Psq^L^ antibody (Rabbit 1:200) recognizing the epitope encompassing residues 92-106. This epitope was designed in the laboratory of Dr. María Domínguez and synthetized by SDIX using SDIX Genomic Antibody Technology® and Eurogentec. Images were captured on a Leica TCS-NT Confocal microscope.

### Cell culture, transfections and western analysis {#S17}

Kc167 cells (DGRC cat. no. 1) were maintained in SFX medium supplemented with 10% inactivated fetal bovine serum (Invitrogen, ref. \#10108-165) and penicillin/streptomycin stock of antibiotics (Sigma P4333-100ML) at 25°C without CO~2~. Ecdysone treatment was done by incubation with 0.5 μM 20-Hidroxyecdysone (20-HE) (Sigma H5142-10MG) in culture medium for 3 hr; vehicle control with ethanol was performed in parallel. Western analysis was performed using standard procedures. PVDF membranes were incubated with one of the following primary antibodies: polyclonal rabbit a-Psq^tot^ (1:2000), polyclonal rabbit a-Psq^L^ (1:2000), a-Actin (Sigma A2066, 1:500), rat a-Mod(mdg4)2.2 (1:2000), rabbit a-CP190 (1:2000). Proteins were detected using the chemiluminescent substrate ECL (Pierce, 32209), LAS-100 detector (FujiFilm) and Imagen Reader LAS-1000 software (FujiFilm). Transient transfection experiments were done in 6 well plates with 8 × 10^5^ cells per well in 2 mL of medium and 1 μg of total DNA per well. The amount of each plasmid was adjusted to obtain equimolar concentrations. Cells were transfected using Cellfectin II Reagent (Invitrogen 10362-100). dsRNA was generated using the Megascript T7 High Yield Transcription Kit (Ambion NC. 1404051). Primers used for the RNAi KD recognizing all isoforms of Psq are For 5′-TAATACGACTCACGCTGCCCTGCTTA-3′; Rev 5′- TAATACGACTCACAAGGCTCA CAATG-3′).

### qPCR {#S18}

Total RNA was isolated from Kc167 cells using the RNeasy Mini Kit (Cat. 74106, QIAGEN) and treated with DNaseI to eliminate the remaining DNA from samples according to the manufacturer's protocol. RNA (1 μg) was reverse-transcribed using SuperScript III Reverse Transcriptase and Oligo(dT) primers (Cat. 18418020, Invitrogen). Quantitative PCR reactions were performed using Power SYBR Green PCR Master Mix (Applied Biosystems), 10 ng of template cDNA, and 222 nM gene-specific primers in a 7500 Real-time PCR system (Applied Biosystems). Three separate samples were collected for each condition and triplicate measurements were conducted. Primers were designed using the Primer Quest online tool (<https://www.idtdna.com/site/account/login?returnurl=%2FPrimerQuest%2FHome%2FIndex>). Data is presented as mean ± standard error of the mean. Statistical analyses were performed using the two tailed Student's t test.

### Co-immunoprecipitation assays {#S19}

To detect interaction between Pipsqueak and Mod2.2, Kc167 cells were grown in 10 cm plates. One plate with 5x10^6^ cells in 10 mL medium was used for each condition. Co-IPs between Psq^L^and Mod2.2 were done using antibodies against the corresponding proteins and 1 μg of rabbit anti-Mod(mdg4)2.2, rabbit Psq^L^ and rabbit Psq total. After electrophoresis and transfer, membranes were incubated with the following primary antibodies: rabbit polyclonal Psq^tot^ antibody (1:2000), rabbit polyclonal Psq^L^ antibody (1:2000), α-actin (Sigma, A2066,1:500), and rat a-Mod(mdg4)2.2 (1:2000). After overnight incubation at 4°C, membranes were incubated for 1 hr at room temperature with secondary antibodies: HRP-conjugated rabbit a-IgG (Sigma, A9169,1:10000), HRP-conjugated mouse a-IgG (Jackson, 115-035-062,1:5000) or HRP-conjugated Rat a-IgG (Jackson, 712-035-153), and diluted in PBS with 0.1% Tween-20 and 3% BSA. Proteins were detected using the ECL chemiluminescent substrate (Pierce, 32209), LAS-100 detector (Fujifilm) and LAS-1000 Image Reader software (FujiFilm).

### ChIP-seq {#S20}

Chromatin immunoprecipitation was performed as described ([@R3]), with 5 μl of primary antibody. To generate sequencing libraries, ChIP DNA was prepared for adaptor ligation by end repair (End-It DNA End Repair Kit, Epicenter ER0720) and addition of 'A' base to 3' ends (Klenow 3′-5′ exo, NEB M0212S). Illumina adaptors (Illumina PE-102-1001) were titrated based on the prepared DNA ChIP sample concentration and ligated with T4 ligase (NEB M0202S). Ligated ChIP samples were amplified by PCR using Illumina primers and Phusion DNA polymerase (NEB F-530L), and size selected for 200-300 bp by gel extraction. Two ChIP biological replicates were sequenced at the HudsonAlpha Institute for Biotechnology using an Illumina HiSeq 2500 instrument. To ensure antibody specificity during ChIP-seq, western blots were performed using the exact same nuclei isolation procedure. Cells were crosslinked for 10 minutes in 1% formaldehyde followed by inactivation in 125 M glycine for 5 min and by two washes in cold PBS. Afterward, samples were incubated in cell lysis buffer (5 mM PIPES pH 8, 85 mM KCl, 0.5% NP40, with protease inhibitors) for 15 min on ice. Nuclei were then collected via centrifugation and incubated in 200 μl nuclei lysis buffer (50 mM Tris HCl pH 8, 10 mM EDTA, 1% SDS, with protease inhibitors) for 20 min on ice. Samples were then diluted with 100 μl cold IP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 Tris HCl pH8, 167 mM NaCl, with protease inhibitors). This was followed by sonication for 28 cycles of 30 / 60 s on / off at 4°C. Chromatin was isolated by centrifugation for 10 min at max speed and keeping the supernatant. To de-crosslink and denature proteins in preparation for western blot, samples were incubated at 99°C for 10 min in 2X SDS loading buffer.

### HiChIP Library Preparation {#S21}

HiChIP samples were prepared as described in [@R40] but using Pc or Psq^S^ antibodies. Kc167 cells were crosslinked in 1% formaldehyde for 10 min at room temperature and stopped in 0.2 M glycine for 5 min. Cells were pelleted and nuclei were isolated in 500 μl cold Hi-C lysis buffer (10 mM Tris-HCl pH8, 10 mM NaCl, 0.2% Igepal CA-630, and 1x Protease Inhibitors (Roche 11873580001) and incubated on ice for 1 h followed by centrifugation at 2500 r*cf*. for 5 min at 4°C. Nuclei were resuspended in 100 μl 0.5% SDS, and incubated for 5 min at 65°C. We then added 290 μl of H~2~O and 50 μl of 10% Triton X-100, with an incubation for 15 min at 37°C. Chromatin was digested with 50 μl of 10x *DpnII* buffer and 200 u of *DpnII* (NEB R0543) overnight at 37°C with rotation. The next day, *DpnII* was inactivated at 65°C for 20 min, and each sample was divided into two reactions and allowed to cool to room temperature. Biotin fill-in was done with 22.5 μl of water, 1.5 μl each of 10 mM dTTP, dATP, and dGTP, 15 μl of 1 mM biotin-16-dCTP (Jena Bioscience JBS-NU-809-BIO16), and 8 μl of 5 u/μl DNA polymerase I Large (Klenow) fragment (NEB M210) at 37°C for 1.5 h. Afterward chromatin was ligated for 4 h at room temperature with the addition of 663 μl H~2~0,120 μl 10x NEB T4 DNA Ligase buffer, 100 μl 10% Triton X-100, 12 μl 10 mg/ml BSA, and 5 μl 400 u/μl T4 DNA Ligase (NEB M0202).

Following chromatin ligation, nuclei were pelleted and resuspended in 200 μl cold Nuclei Lysis Buffer (50 mM Tris-HCl pH 9,10 mM EDTA, 1% SDS, and 1x Protease Inhibitors) and incubated on ice for 20 min. Afterward we added 100 ml cold IP Dilution Buffer (0.01% SDS, 1.1% Triton X-100,1.2 mM EDTA, 16.7 Tris-HCl pH 8,16.7 mM NaCl, and 1x Protease Inhibitors) and sonicated. DNA for downstream libraries prepared with the standard protocol was sonicated to approximately 300 bp fragments, while DNA for libraries prepared with Tn5 transposase were sonicated to approximately 1 kb fragments. Cell debris was pelleted, and the supernatant was transferred into a new 1.5 mL tube for immunoprecipitation. To remove nonspecific IP, each sample was precleared before immunoprecipitation by taking 10 μl Protein A and 10 μl Protein G magnetic beads, washing 3x in 0.5% BSA in 1x PBS, followed by incubation with 10 μl pre-immune rabbit serum in 500 μl 0.5% BSA/PBS for 4 h at 4°C with rotation. Beads were then washed with 1 mL 0.5% BSA/PBS for 2 min at room temperature, followed by 2 washes in 1 mL IP Dilution Buffer, and resuspension in 300 μl cold IP Dilution Buffer. Beads with each antibody were prepared in the same manner. Before the IP, chromatin was diluted 5-fold with cold IP Dilution Buffer and incubated with pre-cleared beads for 1-2 h at 4°C with rotation. The unbound portion was then transferred to antibody-coated beads and incubated overnight at 4°C with rotation. After IP, samples were washed 3x with Low Salt Buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA pH 8, 20 mM Tris-HCl pH 8,150 mM NaCl), 2x with High Salt Buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA pH 8, 20 mM Tris-HCl pH 8, 500 mM NaCl), 2x with LiCl Buffer (10 mM Tris-HCl pH 8, 1 mM EDTA, 0.25 M LiCl, 1% Igepal CA-630, 1% DOC), and 1x with TE buffer. DNA was eluted 2x using IP elution buffer (0.1 M NaHCO3, 1% SDS) for 10 min at room temperature, followed by 5 min at 37^°^C and transferring to a new tube, combining eluates. For crosslink reversal, we added 20 μl 5 M NaCl, 8 μl 0.5 M EDTA and 16 μl 1 M Tris-HCl pH8, incubating 1.5 h at 68°C. Afterward we added 8 μl proteinase K and incubated at 50°C for 2 h. DNA was then precipitated in ethanol with sodium acetate, resuspending in 300 μl 10 mM Tris-Cl pH 8.5. To enrich for ligation events, we prepared Streptavidin beads by washing in 400 μl TWB (5 mM Tris-HCl pH 7.5, 0.5 mM EDTA, 1 M NaCl, 0.05% Tween 20) and resuspending in 300 μl of 2x Binding Buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA, 2 M NaCl). Beads were added to the sample and incubated at room temperature for 15 min with rotation. Samples were then washed 2x in TWB and the standard Hi-C library preparation was followed for some replicates ([@R36]) while the Tn5 library prep was followed for others ([@R31]).

### Data Processing {#S22}

#### Analysis of ChIP-seq data {#S23}

Sequences were mapped to the dm6 genome with Bowtie 0.12.3 ([@R25]) using default settings. Statistics for each ChIP-seq experiment can be found in [Table S1](#SD1){ref-type="supplementary-material"}. Peaks were then called with MACS2 with IgG as a control and a p value of 1e-3. Peaks detected by the Psq^L^ and Psq^tot^ antibodies were first combined into one list and overlapping summits +− 200 bp were merged into one peak. This total peak list was then categorized into Psq^L^ sites such that read counts were greater than 99.5% of random regions for Psq^L^ (FDR \< 0.005) but less than that for Psq^S^. The remaining peaks were then split into Psq^S^ peaks, i.e., those with signal only in Psq^S^ (FDR \< 0.005), and peaks with signal in both Psq^L^and Psq^S^to determine Psq^L&S^ sites. Published ORGANIC ChIP-seq was mapped similarly to dm6 and then filtered for reads ≤ 50 bp in size as was done previously ([@R23]). Changes in ChIP-seq occupancy after ecdysone treatment were measured by MAnorm using the parameters recommended for transcription factor binding ([@R46]). Motifs for Psq were identified by MEME-ChIP using default settings ([@R29]) and genomic coordinates were identified via fimo with a q-value \< 0.05. Overlaps between peaks and motifs were evaluated using bedtools.

#### Analysis of Hi-C and HiChIP Data {#S24}

Sequenced reads were mapped to the *Drosophila* dm6 genome, further processed to remove duplicates and self-ligations using the Juicer pipeline, and visualized using Juicebox ([@R9], [@R10]). Statistics for each library can be found in [Tables S2](#SD1){ref-type="supplementary-material"} and [S3](#SD1){ref-type="supplementary-material"}. Pc loops were identified using Chicago ([@R4]) at 5 kb resolution using the recommended parameters. Due to the intensity of Pc loops, several bins surrounding the midpoint of the loop were called significant ([@R36]), thus only the pixel with the highest signal compared to the surrounding interactions was called. Enhancer-promoter interactions were called in H3K27ac HiChIP data ([@R40]) using the Chicago package to identify statistically significant interactions ([@R4]). These interactions were filtered to obtain those connecting STARR-seq enhancers to promoters. These interaction anchors were then overlapped with Psq binding sites to identify Psq-bound enhancer-promoter interactions. 2D metaplots were obtained by taking the median distance normalized Hi-C or HiChIP signal for the area surrounding either point-to-point interactions or across scaled regions. Scores for point-to-point interaction metaplots were calculated similar to APA ([@R36]) but instead of sums of interactions, which are affected by the variance, we took the median signal at the interaction point compared to the top right corner. Pc domains were identified by extracting 1 kb bins with more than 3-fold Pc ChIP-seq signal compared to IgG. Regions with more than 10 bins of enriched Pc with each bin within at least a 4 kb distance were kept. Compartmental interactions surrounding Pc domains in [Figure 3E](#F3){ref-type="fig"} were visualized by the Pearson correlation matrix of the Hi-C data. Interaction strength between Pc domains and other features were calculated from the average distance normalized signal between these domains and other features.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S25}
---------------------------------------

Hi-C and HiChIP data represent the signal obtained from a population of cells, n = 20 million or n = 100 million respectively. Mapping statistics for HiChIP data were generated using Juicer ([@R10]) and are displayed in [Tables S2](#SD1){ref-type="supplementary-material"}--[S4](#SD1){ref-type="supplementary-material"}. Metaplots of Hi-C or HiChIP data represent the median signal in each bin surrounding a central point or the median signal across bins scaled for features of non-uniform sizes, e.g., genes. Central point enrichment in Hi-C or HiChIP metaplots, termed the APA score ([@R36]), was calculated by dividing the signal in the center bin by the average signal across a 3x3 square in the upper right corner. The results of this test are labeled in the figures where applicable. Profiles of sequencing data across genomic loci represent the average or median signal as described on each figure and were generated using ngs.plot ([@R47]) or by using custom scripts. Correlations were evaluated using a Pearson correlation test and are displayed in the figures and in the figure legends. Boxplots were generated in R and the center line represents the median, the box represents the interquartile range (IQR) of quartiles Q1-Q3, and lower and upper whiskers represent the Q1 − 1.5\*IQR or Q3 + 1.5\*IQR. Significant differences were evaluated by the Wilcoxon Rank Sum test in R, the results of which are described in the figure legends.

DATA AND CODE AVAILABILITY {#S26}
--------------------------

ChIP-seq, and HIChIP data are available from NCBI's Gene Expression Omnibus (GEO). The accession number for all the datasets reported in this paper is GEO: GSE118047. Custom scripts were used to generate 2D metaplots of Hi-C and HiChIP data. These scripts are available without restrictions upon request.
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![Psq^L^ Colocalizes with Su(Hw) and Its Associated BTB Domain Proteins in Kc167 Cells\
(A) Integrative genomics viewer (IGV) tracks showing peaks of Psq^L^(green) and Psq^S^ (blue). Peaks in green alone detected by the Psq^L^ antibody are classified as Psq^L^ binding sites, while peaks with a signal in blue alone detected by the Psq^tot^ antibodies, but not the Psq^L^ antibodies, are classified as Psq^S^. Peaks with signals in both ChIP-seq datasets could be either Psq^L^ alone or co-occupied by Psq^L^ and Psq^S^.\
(B) Pie chart showing the number of peaks occupied by each Psq isoform.\
(C) Overlap between Psq^L^ peaks and Su(Hw), GAGA, both, or neither motif.\
(D) Cumulative fraction of Psq^L^ peaks that overlap Su(Hw) motif locations called at varying q values by individual motif occurrences (fimo).\
(E) Heatmap showing ChIP-seq signal for various proteins or histone modifications surrounding Psq^S^ binding sites ± 2 kb. n = 1,962. The STARR-seq signal is from S2 cells, and the ChIP-seq signal is from Kc167 cells and is shown relative to immunoglobulin G (IgG).\
(F) Western analysis of protein extracts from Kc167 cells containing input (left), IP of Psq^L^ (middle), or IgG (right) using antibodies to Mod(mdg4)2.2 (top) or Psq^L^ (bottom).\
(G) Western analysis of protein extracts from Kc167 cells containing input (left), IP of Mod(mdg4)2.2 (middle), or IgG (right) using antibodies against Psq^L^ (top) or Mod(mdg4)2.2 (bottom).\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1539070-f0001){#F1}

![The Psq^S^ Isoform Colocalizes with Pc and GAF at Active Enhancers in Kc167 Cells\
(A) Binding motif detected by multiple expectation maximization (EM) for motif elicitation designed to analyze ChIP-seq (MEME-ChIP) at Psq^S^ peaks.\
(B) Percentage of Psq^S^ peaks that overlap GAGA motifs ranked by ChIP-seq signal intensity (blue). Regions upstream and downstream of Psq^S^ summits were tested for comparison (gray).\
(C) Example region showing Psq^S^ binding sites as peaks with a Psq^tot^ signal (blue), without a Psq^L^ signal (green), and colocalizing with GAF, Pc, CBP, and H3K27ac (black).\
(D) Heatmap showing ChIP-seq signal for various proteins or histone modifications surrounding Psq^S^ binding sites ± 2 kb. n = 6,386. The STARR-seq signal is from S2 cells, and the ChIP-seq signal is from Kc167 cells and is shown relative to IgG.\
(E) IGV track showing an example locus with ChIP-seq signal for Psq^L^ and Psq^tot^ overlapping with both Su(Hw) and GAF.\
(F) ChIP-seq signal for various proteins and histone modifications in a 2-kb region surrounding sites enriched in Psq^L^ and Psq^tot^. n = 2,130. The STARR-seq signal is from S2 cells, and the ChIP-seq signal is from Kc167 cells and is shown relative to IgG.\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1539070-f0002){#F2}

![Pc Loop Anchors Contain Psq^S^ and Form Interactions Distinct from Those Involving Pc-Repressive Domains\
(A) Example locus showing Hi-C in Kc167 cells signals for loops associated with Pc (circles). Tracks showing ChIP-seq for H3K27ac, H3K27me3, Psq^tot^, and Pc are shown above and to the left. Genes are shown at the bottom.\
(B) 2D metaplots of Hi-C (left) and Pc HiChIP (right) data centered on significant interactions called by Pc HiChIP. n = 206. The score indicates the enrichment of the center pixel compared with the top left corner.\
(C) Average ChIP-seq profile for H3K27ac (orange) and H3K27me3 (pink) surrounding Pc loop anchors identified by Pc HiChIP. n = 206. The shaded area indicates SD.\
(D) 2D metaplot of Psq^tot^ HiChIP data centered on significant interactions called by Pc HiChIP. n = 206. The score indicates the enrichment of the center pixel compared with the top left corner.\
(E) Hi-C interaction plot showing an example locus in which two distinct Pc domains interact more strongly with each other (black box) than with other inactive B compartmental domains (green box). Tracks showing H3K27ac, H3K27me3, Pc, and A or B compartmental domains are shown above and to the left.\
(F) Zoomed-in area of the Pc domain shown in (E).\
(G) Boxplot showing the distribution of average interaction signals occurring between Pc domains (Pc-Pc, n = 102), between Pc domains and other inactive B compartmental domains (Pc-B, n = 1,365), or between inactive B compartmental domains (B-B, n = 17,208). p \< 0.001, Wilcoxon test for Pc-Pc versus Pc-B.\
See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1539070-f0003){#F3}

![Psq Colocalizes with EcR at Ecdysone-Induced Genes\
(A) ChIP-seq signal in Kc167 cells for various proteins and histone modifications in a 2-kb region surrounding EcR sites. n = 845. The ChIP-seq signal is shown relative to IgG.\
(B) IGV tracks showing the ChIP-seq signal before and after 20-HE treatment for EcR (red), Psq^L^ (green), Psq^tot^ (blue), and Pc (black). The purple box highlights a region where binding is altered after ecdysone treatment.\
(C) Fold expression changes for genes with overlapping Psq peaks that increase (pink) or are unchanged (gray) after ecdysone treatment. \*p \< 0.01, Wilcoxon test.\
(D) Left: IGV tracks showing the ChIP-seq signal before and after 20-HE treatment for EcR (red), Psq^L^ (green), and Psq^tot^ (blue). Right: expression change of CG44004 after 20-HE treatment relative to the control (CTL) as measured by qPCR.\
(E) Left: IGV tracks showing ChIP-seq signal before and after 20-HE treatment for EcR (red), Psq^L^ (green), and Psq^tot^ (blue). Right: expression change of Vrille after 20-HE treatment relative to the control (CTL) as measured by qPCR.\
See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1539070-f0004){#F4}

![Psq^S^-Bound Enhancer-Promoter Interactions Are Altered during the Ecdysone Response\
(A) Pie graph showing the relative binding of Psq^S^ (purple), Psq^L^ (green), and Psq^L&S^ (pink) at enhancer-promoter interaction anchors determined by H3K27ac HiChIP in Kc167 cells. n = 94,483 interactions.\
(B) 2D metaplot of Psq HiChIP signal around enhancer-promoter interactions determined by H3K27ac HiChIP found in (A). En, enhancers; Prm, promoters.\
(C) Number of STARR-seq ecdysone enhancers (left) compared with random loci (right) that overlap Psq^S^ (purple), Psq^L^ (green), and Psq^L&S^ (pink).\
(D) Psq HiChIP data in a 1-Mb region of chromosome 2R showing changes in the interaction profile after ecdysone treatment (bottom left) compared with the control (top right). ChIP-seq tracks showing Psq^S^ and EcR before (CTL) and after 20-HE treatment. The STARR-seq signal after ecdysone treatment is also shown.\
(E) 2D metaplot of Psq HiChIP data before (top right) and after (bottom left) ecdysone treatment. Regions between STARR-seq ecdysone enhancers and nearby differentially expressed genes were scaled to equally sized bins. n = 86.\
See also [Figure S5](#SD1){ref-type="supplementary-material"}.](nihms-1539070-f0005){#F5}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                    SOURCE                                       IDENTIFIER
  -------------------------------------- -------------------------------------------- ---------------------------------------------------------
  Antibodies                                                                          
  Anti- MD92-106                         This Study                                   N/A
  Anti- MD453-552                        This Study                                   N/A
  Anti-Pc                                ([@R27])                                     N/A
  Anti-EcR                               Hybridoma bank                               Cat\#AB_528209; RRID:AB_528209
  Anti-ISWI                              Gift from John Tamkun                        N/A
  Deposited Data                                                                      
  MD92-106 ChIP-seq Kc167 Cells          This Study                                   GSE118047
  MD453-552 ChIP-seq Kc167 Cells         This Study                                   GSE118047
  MD92-106 20-HE ChIP-seq Kc167 Cells    This Study                                   GSE118047
  MD453-552 20-HE ChIP-seq Kc167 Cells   This Study                                   GSE118047
  ORGANIC Psq ChIP-seq S2 cells          ([@R23])                                     GSE45672
  EcR ChIP-seq Kc167 Cells               This Study                                   GSE118047
  EcR 20-HE ChIP-seq Kc167 Cells         This Study                                   GSE118047
  MD453-552 HiChIP Kc167 Cells           This Study                                   GSE118047
  MD453-552 20-HE HiChIP Kc167 Cells     This Study                                   GSE118047
  Pc HiChIP Kc167 Cells                  This Study                                   GSE118047
  Pc 20-HE HiChIP Kc167 Cells            This Study                                   GSE118047
  Pc ChIP-seq Kc167 Cells                This Study; ([@R27])                         GSE118047; GSE63518
  Pc 20-HE ChIP-seq Kc167 Cells          This Study                                   GSE118047
  GAF ChIP-seq Kc167 Cells               ([@R6])                                      GSE80702
  CBP ChIP-seq Kc167 Cells               ([@R27])                                     GSE63518
  ISWI ChIP-seq Kc167 Cells              This Study                                   GSE118047
  BEAF32 ChIP-seq Kc167 Cells            ([@R27]; [@R59])                             GSE30740; GSE63518
  CAPH2 ChIP-seq Kc167 Cells             ([@R27]; [@R55])                             GSE54529, GSE63518
  Chromator ChIP-seq Kc167 Cells         ([@R27]; [@R55])                             GSE54529, GSE63518
  CP190 ChIP-seq Kc167 Cells             ([@R55]; [@R59])                             GSE30740, GSE54529
  CTCF ChIP-seq Kc167 Cells              ([@R59])                                     GSE30740
  DREF ChIP-seq Kc167 Cells              ([@R27]; [@R59])                             GSE63518, GSE39664
  H3K27ac ChIP-seq Kc167 Cells           ([@R59])                                     GSE36374
  H3K27me3 ChIP-seq Kc167 Cells          ([@R40])                                     GSE89244
  H3K4me1 ChIP-seq Kc167 Cells           ([@R27]; [@R59])                             GSE36374, GSE63518
  H3K4me3 ChIP-seq Kc167 Cells           ([@R27])                                     GSE63518
  Hi-C Kc167 Cells                       ([@R6])                                      GSE80702
  L3mbt ChIP-seq Kc167 Cells             ([@R27]; [@R54])                             GSE36393, GSE63518
  Mod(mdg4)2.2 ChIP-seq Kc167 Cells      ([@R54])                                     GSE36393
  Nup98 ChIP-seq Kc167 Cells             ([@R6])                                      GSE80702
  Rad21 ChIP-seq Kc167 Cells             ([@R27]; [@R55])                             GSE54529, GSE63518
  Su(Hw) ChIP-seq Kc167 Cells            ([@R59])                                     GSE30740
  Z4 ChIP-seq Kc167 Cells                ([@R27])                                     GSE63518
  STARR-seq                              ([@R48]; [@R60])                             GSE47691, GSE57876
  Oligonucleotides                                                                    
  5′- CGACGGCAATTACATACCAG --3′          Psq-L&SFor                                   N/A
  5′- GTTCGTGCTCGTGGTCCT-3′              Psq-L&S Rev                                  N/A
  5′- CAACAGCAACAACACCCAGA --3′          Eip75B-RA For                                N/A
  5′- CAGATCGGCACATGGCTTT --3′           Eip75B-RA Rev                                N/A
  5′- GCACAGGCGCATTGTGATA --3′           Eip75B-RD For                                N/A
  5′- GGCGAAGAACTCCCGATATT --3′          Eip75B-RD Rev                                N/A
  5′- GATCCATAAGTCCGCAGTCAAA --3′        Vrille For                                   N/A
  5′- CTATGGAGATGGAATGATGGCC --3′        Vrille Rev                                   N/A
  5′- GCGGCCTATCTGTCTACTATTG --3′        CG44004 For                                  N/A
  5′- ACGGAGCAATCTACGAAACC --3′          CG44004 Rev                                  N/A
  Experimental Models: Cell Lines                                                     
  *D. melanogaster*: Cell line Kc167     Drosophila Genomics Resource Center (DGRC)   FlyBase: FBtc0000001
  Software and Algorithms                                                             
  Juicebox                               ([@R9])                                      <http://aidenlab.org/juicebox/>
  Juicer                                 ([@R10])                                     <http://aidenlab.org/juicer/>
  Chicago                                ([@R4])                                      <http://regulatorygenomicsgroup.org/chicago>
  ngsplot                                ([@R47])                                     <https://github.com/shenlab-sinai/ngsplot>
  MANORM                                 ([@R46])                                     <http://bioinfo.sibs.ac.cn/shaolab/MAnorm/MAnorm.htm>
  Bowtie2                                ([@R25])                                     <http://bowtie-bio.sourceforge.net/bowtie2/index.shtml>
  MACS2                                  ([@R61])                                     <https://github.com/taoliu/MACS>

###### Highlights

-   Psq^L^ and Psq^S^ variants play distinct roles in gene expression and tumorigenesis

-   Psq^S^ colocalizes with GAF, CBP, ISWI, H3K27ac, and Pc at enhancers

-   Psq^S^ and Pc form loops, whereas Pc domains mediate compartmental interactions

-   Psq^S^ and Pc-bound enhancers respond to ecdysone, altering 3D chromatin interactions
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